© 2022 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
May 06, 2022
Steve R. Ommen, MD, leads a review of common mutations seen in hypertrophic cardiomyopathy and the role of biomarkers and genetic testing in HCM.
Martin S. Maron, MD, discusses the incidence and prevalence of hypertrophic cardiomyopathy and age of disease expression.
OSPREY Trial Suggests THN Therapy Effective in Moderate to Severe OSA
Severe Asthma Exacerbation Risk Reduced with Combined Albuterol-Budesonide
Sanjiv Chopra, MD: Treatments for NAFLD on the Way